CHF Technologies brings in $360K for heart failure treatments
CHF Technologies, a company that develops surgical equipment to treat congestive heart failure, has raised $360,000 of an expected $10.8 million round of debt and equity, according to a filing with the SEC. The San Ramon, Calif. company has previously been backed by Telegraph Hill… Continue Reading
Estech pays $1.4M to settle Medicare fraud suit
Endoscopic Technologies, maker of tools for non-invasive heart surgeries that does business as Estech, says it will pay $1.4 million to settle claims that it gave kickbacks to health-care providers that used its devices, reports VentureWire.
The same suit alleges the San Ramon, Calif.-based company instructed… Continue Reading
Estech pumps in $8M for heart surgery tools
Endoscopic Technologies, a company known as Estech that makes devices for minimally-invasive heart surgeries, has tacked $8 million onto an open second round of funding, bringing its total to $19.3 million. The new money will be used to boost the San Ramon, Calif. company to… Continue Reading
Endoscopic Tech nabs $11M for heart surgery tools
Medical device maker Endoscopic Technologies brought in an $11 million tranche of second-round funding from Boston Scientific, Telegraph Hill Partners and Saints Capital. The money will be used to further develop the San Ramon, Calif. company’s line of devices that aid in cardiothoracic surgeries like… Continue Reading
Life sciences briefing: Wednesday, Jan. 9, 2008
TODAY’S HEADLINES:
MRI image-analysis firm Confirma receives $18M (release)
Specialty pharma Zogenix raises $18M (release)
Arcion pulls in $8.8M for topical pain gel (release)
Bayhill Therapeutics files for $87M IPO (Edgar)
Peakdale Molecular, chemistry-services provider, raises £1M (release)
Radiopharmaceutical maker Cellectar draws in $13M (release)
Critical-care drug maker Ikaria names Daniel Tasse… Continue Reading
Life sciences briefing: Monday, Dec. 10, 2007
TODAY’S HEADLINES:
Fundamental Applied Biology pulls in $21M for proteins without cells (release)
Diagnostics maker Asuragen receives $19M (release)
Stroke-device maker Neurovasx raises $8.5M (release)
Cancer-vaccine maker ImmunoVaccine Tech buys Immunotope, seeks $15M (release)
Vascular imager CardioSpectra sells itself to Volcano for $25M (release)
Spinal-implant maker Altiva sells to Exactech for… Continue Reading
Life sciences briefing: Tuesday, Oct. 9, 2007
Featured companies: AngioScore, Forsight Labs, Genoptix, Metastatix, Optherion, QLT
UPDATED: See below.
Artery opener AngioScore pulls in $30M — AngioScore, a Fremont, Calif., maker of balloon catheters used to open up clogged arteries, raised $30 million in a fifth funding round. Investors included Telegraph Hill Partners, Psilos Group Management,… Continue Reading
Life sciences briefing: Thursday, Sept. 13, 2007
Featured companies: Aldagen, LDR, Lyten Endoscopy, MachLabs, Permatox, TeleMedicine Clinic, ThromboVision
Spinal-implant maker LDR raises $25M — Austin, Texas-based LDR, a maker of spinal implants, raised $25 million in a third funding round. Investors included Telegraph Hill Partners, Austin Ventures, Rothschild Private Equity and PTV Sciences.
LDR sells… Continue Reading
PneumRx, device maker for lung cancer, emphysema, raises $27M
PneumRx, a maker of medical devices that diagnose and treat lung cancer and Chronic Obstructive Pulmonary Disease (COPD, or emphysema), said it has raised a $27 million in a second round of funding.
Adams Street Partners and Telegraph Hill Partners led the round, which also… Continue Reading